Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Erin Nurre
CONTACT
Mona Qureshi
CONTACT
Lead
Zai Lab (Shanghai) Co., Ltd.
With
This is an open-label, ascending, multiple-dose, phase 1 study evaluating ZL-1310 as a single agent, in combination with Atezolizumab, and in combination with Atezolizumab and Carboplatin in subjects with extensive SCLC.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted